SLS

Conviction 80HealthcareScan · Tue, Sep 8, 2026

SLS$13.96+0.69%

ResistanceSupportVol 14

Vol MA14 8.07M

Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8

WSB mentions · 24h changelatest -44.44%· 5 mentions

Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8

SELLAS Life Sciences Group, Inc.PHARMACEUTICAL PREPARATIONSwww.sellaslifesciences.com ↗

Price13.96

Change+0.69%

Gap-1.30%

Rel volume1.01×

Avg volume7.3M

Avg $ vol100.06M

SMA 2013.48

SMA 5012.83

SMA 2006.86

Price vs 50+8.80%

Price vs 200+103.31%

MA stackbullish

50/200 cross—

Supertrendup · 10.94

RSI (14)55

MACD hist-0.06

MACD crossbear · 4d

Stoch %K / %D43 / 42

ADX (14)35

+DI / −DI27 / 12

RSI divergence—

MACD divergence—

ATR %+8.29%

ADR %8.26%

52w high15.46

52w low1.39

From 52w high-9.73%

Above 52w low+903.96%

New 52w highNo

SqueezeOff

Bollinger width29.82%

%B0.62

Donchian pos64.42%

Donchian high15.67

Donchian low10.85

AVWAP (52w high)13.05

vs AVWAP high+6.97%

AVWAP (52w low)7.24

vs AVWAP low+92.66%

OBV trendUp

Chaikin MF (20)0.08

Today vs 20d1.01×

Avg vol (14d)8.07M

Avg vol (20d)7.3M

Avg $ vol (20d)100.06M

Market cap2.82B

RS 3m (vs SPY)+63.98%

RS 6m (vs SPY)+136.09%

RS line new highNo

Trend template8/8

Technical rank90.1

1 week+4.61%

1 month+16.19%

3 months+74.87%

6 months+134.14%

1 year+630.63%

YTD+220.80%

P/E-104.91

P/B20.47

P/S—

P/FCF-99.25

EPS-0.2500

Div yield—

ROE-19.51%

ROA-18.48%

Debt/Eq0.00

Current18.83

EV/EBITDA-95.26

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth13.01%

Price target27.50

Target upside97.06%

Analyst ratingBuy

Institutional40.73%

Ent. value2.68B

Revenue0

Net income-9.61M

Gross profit869K

Free cash flow-28.39M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out196.63M

Employees13

ListedWed, Mar 12, 2008

Free float182.12M

Float %98.7%

Short interest56.37M

Days to cover10.4d

Short volume57.7%

Squeeze score77 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank90.1 / 100

Group rank96 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance15.62

Support10.02

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SLS

All disclosures →

No recent disclosed trades by Congress in SLS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SLS · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Stergiou Angelos M. President and CEO · Common Stock · 2026-06-16	Grant	1.06M	—	2026-06-16	2026-06-18

SEC filings

EDGAR filings in SLS · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.